Abstract
Ever since the identification of the genetic cause of fragile X syndrome as the expansion of an unstable trinucleotide sequence, several diagnostic strategies have evolved from molecular studies. However, we still lack a simple test suitable for population screening. We have therefore developed a nonisotopic polymerase chain reaction (PCR)-based technique for the identification of fragile X full mutations among men, with easy visualization of the PCR products on silver-stained polyacrylamide gels. The technique consists of PCR amplification with primers that flank the trinucleotide repeats, with a product of 557 by for the (CGG)29 allele. Conditions were established such that full mutations failed to amplify and were thus identified with 98% sensitivity compared with Southern blot analysis. To produce an indispensable internal control we added to the reaction a third primer, internal to this fragment, allowing the multiplex amplification of a monomorphic band corresponding to a CG-rich stretch 147 by upstream of the polymorphic region. In trials involving 41 patients and 74 controls, the PCR-based test here described showed specificity of more than 98.6%, accuracy of 99% and a sensitivity of 98%. Thus, although not suitable for medical diagnosis, it constitutes a useful tool for screening for the fragile X syndrome in populations of mentally retarded males.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Brown WT, Houck GE Jr, Jeziorowska A, Levinson FN, Ding X, Dobkin C, Zhong N, Henderson J, Brooks SS, Jenkins EC (1993) Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test. JAMA 270: 1569–1575
D'Aquila RT, Bechtel LJ, Videler JA, Eron JJ, Gorczyca P, Kaplan JC (1991) Maximizing sensitivity and specificity of PCR by pre-amplification heating. Nucleic Acids Res 19: 3749
Erster SH, Brown WT, Goonewardena P, Dobkin CS, Jenkins EC, Pergolizzi RG (1992) Polymerase chain reaction analysis of fragile X mutations. Hum Genet 90: 55–61
Fu Y-H, Kuhl DPA, Pizzuti A, Pieretti M, Sutcliffe IS, Richards S, Verkerk AJMH, Holden JJA, Fenwick RG Jr, Warren ST, Oostra BA, Nelson DL, Caskey CT (1991) Variation of the CGG repeat at the fragile X results in genetic instability: resolution of the Sherman paradox. Cell 67: 1047–1058
Gustavson K-H, K:son HB, Holmgren G (1986) Prevalence of the fragile-X syndrome in mentally retarded boys in a Swedish county. Am J Med Genet 23: 581–587
Hagerman RS (1991) Physical and behavioral phenotype. In: Hagerman RS, Silverman HC (eds) Fragile X syndrome: diagnosis, treatment and research. Johns Hopkins University Press, Baltimore London, pp 3–68
Heitz D, Devys D, Imbert G, Kretz C, Mandel J-L (1992) Inheritance of the fragile X syndrome: size of the fragile X premutation is a major determinant of the transition to full mutation. J Med Genet 29: 794–801
Kremer EJ, Pritchard M, Lynch M, Yu S, Holman K, Bayer E, Warren SYT, Sclessinger D, Sutherland GR, Richards RI (1991) Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CGG)n. Science 252: 1711–1714
McColongue L, Brow MAD, Innis MA (1988) Structure-independent DNA amplification by PCR using 7-deaza-2′-deoxy-guanosine. Nucleic Acids Res 16: 9869
Mingroni-Netto RC, Rosenberg C, Vianna-Morgante AM, Pavanello RCM (1990) Fragile X frequency in mentally retarded population in Brazil. Am J Med Genet 35: 22–27
Mingroni-Netto RC, Haddad LA, Vianna Morgante AM (1996) The size of CGG repeats of theFMR1 locus in premutated and fully mutated heterozygotes and their offspring: implications for the origin of mosaicism. Am J Med Genet (in press)
Oberlé I, Rousseau K, Heitz D, Kretz C, Devys D, Hanauer A, Boué J, Bertheas MF, Mandel JL (1991) Instability of a 550base pair DNA segment and abnormal methylation in fragile X syndrome. Science 252: 1097–1102
Pena SDJ, Macedo AM, Gontijo NF, Medeiros AM, Ribeiro JCC (1991) DNA bioprints: simple non-isotopic DNA fingerprints with biotinylated probes. Electrophoresis 12: 146–152
Pergolizzi RG, Erster SH, Goonewardena P, Brown WT (1992) Detection of full fragile X mutation. Lancet 339: 271–272
Pieretti M, Zhang F, Fu Y-H, Warren ST, Oostra BA, Caskey CT, Nelson DL (1991) Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 66: 817–822
Rousseau F, Heitz D, Biancalana V, Blumenfeld S, Kretz C, Boué J, Tommerup N, Van Der Hagen C, DeLozier-Blanchet C, Croquette M-F, Gilgenkrantz S, Jalbert P, Voelckel M-A, Oberlé I, Mandel J-L (1991) Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation. N Eng J Med 325: 1673–1681
Santos FR, Pena SDJ, Epplen IT (1993) Genetic and population study of an Y-linked tetranucleotide repeat DNA polymorphism with a simple non-isotopic technique. Hum Genet 90: 655–656
Sherman SL, Morton NE, Jacobs PA, Turner G (1984) The marker (X) syndrome: a cytogenetic and genetic analysis. Ann Hum Genet 48: 21–37
Snow K, Doud LK, Hagerman R, Pergolizzi RG, Erster SH, Thibodeau SN (1993) Analysis of a CGG sequence at the FMR-1 locus in fragile X families and in the general population. Am J Hum Genet 53: 1217–1228
Sutcliffe IS, Nelson DL, Zhang F, Pieretti M, Caskey CT, Saxe D, Warren ST (1992) DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum Mol Genet 1: 397–400
Van den Ouweland AMW, De Vries BBA, Bakker PLG, Deelen WH, De Graaff E, Van Hemel JO, Oostra BA, Niermeijer MF, Halley DJJ (1994) DNA diagnosis of the fragile X syndrome in a series of 236 mentally retarded subjects and evidence for a reverse of mutation in the FMR-1 gene. Am J Med Genet 51: 482–485
Verkerk AJMH, Pieretti M, Sutcliffe IS, Fu Y-H, Kuhl DPA, Pizzuti A, Reiner O, Richards S, Victoria MF, Zhang F, Eussen BE, Van Ommen G-JB, Blonden LAI, Riggins GJ, Chastain JL, Kunst CB, Galjaard H, Caskey CT, Nelson DL, Oostra BA, Warren ST (1991) Identification of a gene (FMR-1) containing a CGG repeat coincident with the breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65: 905–914
Walsh PS, Metzger DA, Higuchi R (1991) Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. BioTechniques 10: 506–513
Webb TP, Bundey SE, Thake AIJ, Todd J (1986) Population incidence and segregation ratios in the Martin-Bell syndrome. Am J Med Genet 23: 573–580
Wu DY, Ugozzoli L, Pal BK, Qian J, Wallace RB (1991) The effect of temperature and oligonucleotide primer length on the specificity and efficiency of amplification by the polymerase chain reaction. DNA Cell Biol 10: 233–238
Yu S, Pritchard M, Kremer M, Lynch M, Nancarrow J, Baker E, Holman K, Mulley JC, Warren ST, Schlessinger D, Sutherland GR, Richards RI (1991) Fragile X genotype characterized by an unstable region of DNA. Science 252: 1179–1181
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Haddad, L.A., Mingroni-Netto, R.C., Vianna-Morgante, A.M. et al. A PCR-based test suitable for screening for fragile X syndrome among mentally retarded males. Hum Genet 97, 808–812 (1996). https://doi.org/10.1007/BF02346194
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02346194